Novel technologies to diagnose and manage cardiovascular disease.

Lancellotti, Patrizio

doi:10.1080/00015385.2024.2350765

Download

Article (Scientific journals)

Novel technologies to diagnose and manage cardiovascular disease.

Lancellotti, Patrizio

2024 • In Acta Cardiologica, 79 (3), p. 263-266

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/318520

DOI
10.1080/00015385.2024.2350765

PubMed
38770888

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Novel technologies to diagnose and manage cardiovascular disease.pdf

Author postprint (3.05 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Humans; Cardiovascular Diseases/diagnosis/therapy; Diagnostic Techniques, Cardiovascular; Disease Management

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

English

Title :

Novel technologies to diagnose and manage cardiovascular disease.

Publication date :

May 2024

Journal title :

Acta Cardiologica

ISSN :

0001-5385

eISSN :

1784-973X

Publisher :

Taylor & Francis, London, Gb

Volume :

Issue :

Pages :

263-266

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 22 May 2024

Statistics

Number of views

56 (3 by ULiège)

Number of downloads

44 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Lancellotti P, Nchimi A., New approaches to cardiovascular diseases. Acta Cardiol. 2023;78(9):977–979. doi:10.1080/00015385.2023.2267925.
Harskamp RE, De Clercq L. Performance of ChatGPT as an AI-assisted decision support tool in medicine: a proof-of-concept study for interpreting symptoms and management of common cardiac conditions (AMSTELHEART-2). Acta Cardiol. 2024;79(3):358–366. doi:10.10.1080/00015385.2024.2303528.
Kleebayoon A, Wiwanitkit V., Long-term administration of proton pump inhibitors, risk of adverse cardiovascular outcomes? and ChatGPT. Acta Cardiol. 2023;79(3):402. doi:10.1080/00015385.2023.2238537.
Daungsupawong H, Wiwanitkit V., Performance of ChatGPT as an AI-assisted decision support tool in medicine. Acta Cardiol. 2024;79(3):413. doi:10.1080/00015385.2024.2322185.
Teperikidis E, Boulmpou A, Papadopoulos C., Prompting ChatGPT to perform an umbrella review. Acta Cardiol. 2023;79(3):403–404. doi:10.1080/00015385.2023.2240120.
Lancellotti P, Ribeiro Coelho S, Nguyen Trung ML, et al.Special issue on heart failure. Acta Cardiol. 2023;78(2):165–167. doi:10.1080/00015385.2023.2182985.
Lancellotti P., A journey in structural heart failure. Acta Cardiol. 2023;78(10):1065–1067. doi:10.1080/00015385.2023.2281096.
Donal E, Brunet A, Galli E., Can we predict the non-response to cardiac resynchronization therapy?Acta Cardiol. 2014;69(4):366–368. doi:10.1080/ac.69.4.3036651.
Yuecel G, Stoesslein K, Gaasch L, et al.Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease. Acta Cardiol. 2023;79(3):327–337. doi:10.1080/00015385.2023.2277624.
Zandi Z, Eslami M, Kamali F, et al.Comparison of de novo implantation vs. upgrade cardiac resynchronisation therapy: a multicentre experience. Acta Cardiol. 2023;79(3):338–343. doi:10.1080/00015385.2023.2285539.
Pittie G, Lukas P, Massart M, et al.Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay–a new point-of-care. Acta Cardiol. 2023;79(3):351–357. doi:10.1080/00015385.2023.2286423.
Lancellotti P, Fattouch K, Modine T., Is transcatheter aortic valve implantation for aortic stenosis cost-effective?Acta Cardiol. 2023;79(1):95–97. doi:10.1080/00015385.2023.2281110.
Lempereur M, Nguyen-Trung ML, Petitjean H, et al.Leading trends in pacemaker implantation after aortic valve replacement in Italy. Acta Cardiol. 2023;79(1):101–102. doi:10.1080/00015385.2023.2287305.
Lancellotti P, Petitjean H, Postolache A, et al.Focus on valvular heart disease. Acta Cardiol. 2022;77(10):861–863. doi:10.1080/00015385.2022.2159193.
Damas F, Nguyen Trung M-L, Postolache A, et al.Cardiac damage and conduction disorders after transcatheter aortic valve implantation. J Clin Med. 2024;13(2):409. doi:10.3390/jcm13020409.
Ziacchi M, Spadotto A, Palmisano P, et al.Conduction system disease management in patients candidate and/or treated for the aortic valve disease: an Italian survey promoted by Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Acta Cardiol. 2024;79(3):367–373. doi:10.1080/00015385.2024.2310930.
Lancini D, Smith C, Elkhateeb O, et al.Leadless Micra pacemaker implantation in patient with previous senning procedure for dextro-transposition of the great arteries. Acta Cardiol. 2023;78(3):357–361. doi:10.1080/00015385.2023.2176043.
Xu F, Meng L, Lin H, et al.Systematic review of leadless pacemaker. Acta Cardiol. 2023;79(3):284–294. doi:10.1080/00015385.2023.2276537.
Bilehjani E, Fakhari S, Farzin H, et al.Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review. Acta Cardiol. 2023;79(3):267–273. doi:10.1080/00015385.2023.2246200.
Romiti GF, Bonini N, Boriani G., The detrimental interplay between atrial fibrillation and COVID-19: new evidence and unsolved questions. Acta Cardiol. 2024;79(3):410–412. doi:10.1080/00015385.2024.2313938.
Karadavut S, Cetin M, Sahin O., The effect of COVID-19 on the thromboembolic outcomes in atrial fibrillation patients in the long run. Acta Cardiol. 2023;79(3):344–350. doi:10.1080/00015385.2023.2286421.
Omar T, Karakayalı M, Perincek G., Assessment of COVID-19 deaths from cardiological perspective. Acta Cardiol. 2022;77(3):231–238. doi:10.1080/00015385.2021.1903704.
Zhang YP, Gao QY, Gao JW, et al.The association between tinnitus and risk of cardiovascular events and all-cause mortality: insight from the UK Biobank. Acta Cardiol. 2024;79(3):374–382. doi:10.1080/00015385.2024.2324222.
Lancellotti P., Focus on cardiometabolic risk factors. Acta Cardiol. 2023;78(5):515–518. doi:10.1080/00015385.2023.2231702.
Lancellotti P., Special issue on ischaemic heart disease. Acta Cardiol. 2023;78(8):859–862. doi:10.1080/00015385.2023.2256566.
Zhou Y, Wang FR, Wen FF, et al. The association between sodium/glucose cotransporter-2 inhibitors and adverse clinical events in patients with chronic kidney disease: a systematic review and meta-analysis of randomised controlled trials. Acta Cardiol. 2023;79(3):274–283. doi:10.1080/00015385.2023.2250949.
Snel M, Descamps OS., Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium. Acta Cardiol. 2023;79(3):311–318. doi:10.1080/00015385.2023.2256182.
Karabulut D, Karabulut U, Kalyoncuoğlu M, et al.Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipients. Acta Cardiol. 2023;79(3):319–326. doi:10.1080/00015385.2023.2257983.
Khosravi A, Eghbali M, Najafian J, et al.Prediction of blood pressure based on anthropometric measurements in adolescents. Acta Cardiol. 2023;79(3):304–310. doi:10.1080/00015385.2023.2256180.
Abdel-Hady EA., Chromium picolinate supplementation improves cardiac performance in hypoxic rats. Acta Cardiol. 2022;79(3):387–397. doi:10.1080/00015385.2022.2041782.
Stremmel C, Vdovin N, Kellnar A, et al.Impact of moderate altitude exposure on cardiovascular risk. Acta Cardiol. 2021;79(3):383–386. doi:10.1080/00015385.2021.1976449.
Liu H, Ma XF, Dong N, et al.LncRNA PVT1 inhibits endothelial cells apoptosis in coronary heart disease through regulating MAPK1 expression via miR-532-3p. Acta Cardiol. 2023;79(3):295–303. doi:10.1080/00015385.2023.2209448.
Leelaviwat N, Kewcharoen J, Trongtorsak A, et al.Association between periodontal disease and heart failure: a systematic review and meta-analysis. Acta Cardiol. 2023;79(3):405–409. doi:10.1080/00015385.2023.2259192.
Salaun E, Beaudoin J, Sénéchal M., Conduction disorders in cardiac sarcoidosis. Acta Cardiol. 2024;79(3):400–401. doi:10.1080/00015385.2024.2304462.
Zardi EM, Marra A, Pignatelli M, et al.Unstable angina as a result of coronary steal syndrome due to escape flow from a double large coronary-pulmonary artery fistula. Acta Cardiol. 2023;79(3):398–399. doi:10.1080/00015385.2023.2272552.